PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biomedical Sciences, Ajou University Graduate School of Medicine, 164, World cup-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do, 16499, Republic of Korea.\', \'Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.\', \'Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Republic of Korea.\', \'Division of Gastroenterology, Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, 150, Seongan-ro, Seoul, Gangdong-gu, 05355, South Korea.\', \'Department of Biomedical Sciences, Ajou University Graduate School of Medicine, 164, World cup-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do, 16499, Republic of Korea. veritas@ajou.ac.kr.\', \'Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Gyeonggi-do, Republic of Korea. veritas@ajou.ac.kr.\', \'Division of Gastroenterology, Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, 150, Seongan-ro, Seoul, Gangdong-gu, 05355, South Korea. doctorssi@kdh.or.kr.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s40360-022-00549-7
?:hasPublicationType
?:journal
  • BMC pharmacology & toxicology
is ?:pmid of
?:pmid
?:pmid
  • 35039078
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.785
?:rankingScore_hIndex
  • 19
is ?:relation_isRelatedTo_publication of
?:title
  • Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort study.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all